LOVELAND, Colo., Feb. 27, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska's President & Chief Executive Officer will be presenting at the following upcoming conferences in March 2019:
About HeskaHeska Corporation (NASDAQ: HSKA - News) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products. Heska's business is composed of Core Companion Animal Health ("CCA") segment, which represents approximately 85% of revenue, and Other Vaccines, Pharmaceuticals and Products ("OVP") segment, which represents approximately 15% of revenue. CCA segment includes, primarily for canine and feline use, Point of Care Laboratory testing instruments and consumables under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes, primarily for herd animal health, private label vaccine and pharmaceutical production under third party agreements and channels. For further information on Heska and its products, visit www.heska.com.
Advertisement
- March 5, 2019 – Raymond James & Associates' 40th Annual Institutional Investors Conference at the JW Marriott Grande Lakes in Orlando, FL. Mr. Wilson presents formally on March 5 at 1:05 p.m. ET. The audio and slides of the Company's presentation will be available at http://wsw.com/webcast/rj113/hska/ and the webcast will be archived for 7 days following the live presentation. Mr. Wilson will also be available for one-on-one meetings on March 5.
- March 20, 2019 – Jefferies Animal Health & Pet Industry Summit at the Jefferies Conference Center in New York, NY. Mr. Wilson presents formally on March 20 and will be available for one-on-one meetings as well.
Advertisement
About HeskaHeska Corporation (NASDAQ: HSKA - News) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products. Heska's business is composed of Core Companion Animal Health ("CCA") segment, which represents approximately 85% of revenue, and Other Vaccines, Pharmaceuticals and Products ("OVP") segment, which represents approximately 15% of revenue. CCA segment includes, primarily for canine and feline use, Point of Care Laboratory testing instruments and consumables under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes, primarily for herd animal health, private label vaccine and pharmaceutical production under third party agreements and channels. For further information on Heska and its products, visit www.heska.com.
View original content:http://www.prnewswire.com/news-releases/heska-to-present-at-upcoming-conferences-in-march-2019-300802906.html
SOURCE Heska Corporation
